• ICYMI: Pharmacy Updates
• August is National Drug Drop-Off Month

• Gastrointestinal Conditions
• OPA Clinical Bundle
• Essential Cannabis Knowledge For Pharmacy Technicians Program

• Ask the Practice Support Network

• Is Your Financial Future In Order?

• Drug Shortage / Supply Health System Alert: Leucovorin Supply Status Update

• DDD Notice No. 19116 posted August 2, 2019 Health Network System (HNS) and Narcotics Monitoring System (NMS) Outage Notification to Ontario Drug Programs Agencies

• Ontario Garners Attention on Drug Shortages Amidst Cross-border Shopping on Insulin
• University of Toronto Leslie Dan Faculty of Pharmacy Awarded Research Funding for Key Projects
• Pharmacy Technician Conference - May 9, 2020

• Women's Health Conditions
• Medical Devices Training For Pharmacy Technicians
• Delivering A Comprehensive Pharmacy-Based Vaccines Program

• Ask the Customer Experience and Administration Team

• Auto and Home Insurance

• Drug Shortage / Supply Health System Alert: Succinylcholine 20mg/ml US-based Product (Quelicin)

• Status of non-absorbable synthetic surgical mesh for the transvaginal repair of pelvic organ prolapse in Canada
July Issue of Health Product InfoWatch

• OPA Advocates for Seniors Healthcare Services in Public Consultation
• EpiPen 0.3 mg Auto-Injector Shortages
• Sherry Peister Named Recipient of The Canadian Foundation for Pharmacy Pillar of Pharmacy Award

• Identifying Drug Interactions
• Implementing Smoking Cessation Services in the Pharmacy
• Assessing and Prescribing for Minor Ailments – Full Program

• Ask the Practice Support Network
• Summer Member Discounts!
• Member Benefit: RxFiles
• Bonus Offer from TELUS

• Do I Need Life insurance?

• DDD Notice No. 19114 posted July 23, 2019 ODB FORMULARY – EDITION NO. 43, Summary of Changes – July 2019
• DDD Notice No. 19113 posted July 18, 2019 Prescription Forgery Alert

• Tacrolimus and the Risk of Graft Rejection due to Medication Errors: Inadvertent Switching Between Different Oral Formulations
• Pfizer Canada is Reporting a Shortage of EpiPen (0.3 mg) Auto-Injectors and Taking Precautions to Minimize Impact on Canadians

• Justin J. Bates Joins OPA as Chief Executive Officer
• Last chance to participate in OPA’s Member Survey on Immunization
• Health Canada finalizes regulations for the production and sale of edible cannabis, cannabis extracts and cannabis topicals

• Asthma Management: The Essentials
• Billing 101: Ontario Drug Benefit (ODB) and Third-Party Insurance
• Opioid Addictions and Substitution Therapy Online Modules

• Ask the Customer Experience and Administration Team
• Summer Member Discounts!
• Summer of Space at the Ontario Science Centre
• Member Benefit: RxFiles
• Bonus Offers from TELUS

• How do I benefit from OPA’s Long Term Disability Insurance?

• DDD Notice No. 19111 posted July 11, 2019 Drug Shortage / Supply Health System Alert: Rifampin

• Introducing the 2019-20 OPA Board of Directors
• OPA 2018-19 Annual Report: Shifting Resilience
• OPA Survey on Immunization
• Benefits of Immunization - Report from the International Federation on Ageing
• University of Toronto Leslie Dan Faculty of Pharmacy Appointments
• Medical Cannabis Users Survey Results: 1 in 4 medical cannabis users say it's now harder to access cannabis since recreational legalization

• Injections and Immunizations Certificate Program
• The Master Plan for Diabetes Continuing Education Program
• Collaborating with Family Physicians: The Rx for Success

• Ask the Practice Support Network
• Summer member discounts!

• Why Choose OPA Disability Insurance?

• DDD Notice No. 19106 posted July 5, 2019 Health Network System (HNS) and Narcotics Monitoring System (NMS) Outage Notification to Ontario Drug Programs Agencies
• DDD Notice No. 19105 posted July 5, 2019 Notice from the Executive Officer
• DDD Notice No. 19104 posted July 5, 2019 Prescription Forgery Alert
• DDD Notice No. 19103 posted July 5, 2019 Prescription Forgery Alert
• DDD Notice No. 19102 posted July 5, 2019 Prescription Forgery Alert
• DDD Notice No. 19101 posted July 5, 2019 Prescription Forgery Alert
• DDD Notice No. 19100 posted July 5, 2019 Prescription Forgery Alert

• Drug Shortage / Supply Health System Alert: Rofact (rifampin)
• Drug Shortage / Supply Health System Alert: Rifampin
• Drug Shortage / Supply Health System Alert: Leucovorin
• Drug Shortage / Supply Health System Alert: Leucovorin, Fludarabine, Jevtana (Cabazitaxel)

• Drug Supply Health System Alert: Fludarabine Phosphate Injection and Leucovorin Calcium Injection
• Reminder: Call for OPA Committee Members
• Call for abstracts - 2020 Traumatic Brain Injury Conference

• Managing Your Pharmacy: The Business Essentials
• Essential Cannabis Knowledge for Pharmacy Technicians
• Assessing and Prescribing for Minor Ailments - Full program

• Ask the Customer Experience and Administration Team
• Summer deals with Dell member savings!

• Stay insured when leaving the country with OPA’s Emergency Travel Insurance

• Certain older Medtronic MiniMed insulin pumps may be vulnerable to cybersecurity risks
• Health Product InfoWatch - Vaccine safety biannual summary and pms-Methotrexate monograph update

• Second report released from the Premier's Council on Improving Healthcare and Ending Hallway Medicine
• Reminder: UIIP application deadline is June 30, 2019
• OPA in the news:
• Further discussions urged on solutions to opioid crisis
• Perspectives on pharmacare from OPA
• Updated Claim Submission/Reversal and Special Authorization (Allergen) Forms
• ICYMI: Pharmacy student resolutions at OPA AGM
• OPA launches cannabis program for pharmacy technicians

• Injections and Immunizations Certificate Program
• Methadone, Buprenorphine and the Community - live session
• Patient Assessment and Triage

• Ask the Practice Support Network

• Surviving a critical illness

• DDD Notice No. 19098 posted June 25, 2019 Claim Submission/Reversal and Special Authorization (Allergen) forms
• DDD Notice No. 19097 posted June 21, 2019 Prescription Forgery Alert
• DDD Notice No.19096 posted June 21, 2019 Prescription Forgery Alert
• DDD Notice No. 19095 posted June 21, 2019 Prescription Forgery Alert
• DDD Notice No. 19093 posted June 21, 2019 Notice from the Executive Officer
• DDD Notice No. 19092 posted June 20, 2019 ODB FORMULARY – EDITION NO. 43, Summary of Changes – June 2019
• DDD Notice No. 19091 posted June 19, 2019 REMINDER: Proper Claims Submission Process for ODB Recipients Aged 24 Years and Under
• Drug Supply Health System Alert: Etoposide and OncoTICE®

• Important safety information on Alertec (modafinil) and the risk of congenital anomalies

• New changes to the Universal Influenza Immunization Program (UIIP) for the upcoming 2019/2020 season
• Updated evacuation notice for Pikangikum First Nation

• Drugs in Chronic Kidney Disease: Implications for Pharmacists
• Musculoskeletal and Nervous System Conditions
• Implementing Smoking Cessation Services in the Pharmacy

• Check out PxP2019 Conference photos!
• Correction Notice: Ask PSN Question from May 28, 2019

• Business Expense Disability Insurance

• Drug Shortage Notification for certain Products Presented in LifeShield™ and ANSYR™ Syringes
• Drug Supply Health System Alert: Leucovorin Calcium Injection, 10 mg/mL, DIN 02087316
• Drug Supply Health System Alert: Potassium Chloride for Injection Concentrate USP (2mEq/mL) in the 20mL format

• Health Canada warns Canadians of potential cancer risk associated with gentian violet
• Labelling error may lead to patients receiving Linessa 28 birth control pills instead of Linessa 21